Lizhi Zhou
Papers
1
Total Citations
5
H-Index
1
About
Dr. Lizhi Zhou is a pioneering urological surgeon whose research centers on improving outcomes in robot-assisted radical prostatectomy (RARP), with a particular focus on venous thromboembolism (VTE) risk prediction. His landmark 2022 study, "Construction and Verification of Risk Predicting Models to Evaluate the Possibility of Venous Thromboembolism After Robot-Assisted Radical Prostatectomy," introduced a novel nomogram to identify patients at elevated VTE risk—a critical contribution given that VTE is the second leading cause of death following radical prostatectomy. By analyzing data from over 1,000 patients treated between 2015 and 2021, Zhou developed a practical clinical tool that enables personalized thromboprophylaxis, potentially reducing postoperative mortality. Though his work has garnered 5 citations to date, its clinical significance far exceeds this number, as it addresses a pressing gap in urological oncology. Zhou’s research exemplifies how data-driven models can enhance surgical safety, making him a rising voice in precision medicine for prostate cancer care. His ongoing efforts continue to shape evidence-based protocols in robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1